" Cytodyn has about 40,000 doses in stock. With some sort of emergency contingent approval and financing, they can manufacture 100,000 doses/month."

That was Dr. J to Murray on Thursday, April 09, 2020 12:07 AM

Nice that we no longer wonder about our amount of LL inventory.

I didn't continue buying based on expecting any legal case settlement(s) in 2024, let alone being a "contigent upon" pieces, to frwd plans from the current mgt team.

Samsung debt settled & nothing of the past, will stop this from being the platform drug as coined. Even Cytodyn now calls it out as intended goal.

If 10-20% of indications mentioned/listed, comes to fruition, or even starts to look as such, this becomes priceless.

Looking frwd to reading the legal minds comments on the Chronic Inflammation protocol & many thanks in advance.

Cytodyn knows the optics @ steak & it is time to shine by putting their talents on display via .Gov

"Successful" protocol design & everything turns to Interim look. Success there & the share structure really starts to look like future frwd splits:

"Platform Drug".

But do wonder how much progress they will make 1st, before posting @.Gov

Expecting it to be very good work in progress.

Shall see...

Ready to see that protocol!
Ha..